A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy
Clinical trial NCT07582133 · RECRUITING
Trial details
- NCT number
- NCT07582133
- Sponsor
- Chengdu Suncadia Medicine Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-06
- Primary completion
- 2029-07-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.